Anita M Dreyer
Overview
Explore the profile of Anita M Dreyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
588
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Odundo E, Weerts H, Musila L, Ogonda L, Dreyer A, Schneider J, et al.
mSphere
. 2022 May;
7(3):e0102021.
PMID: 35611657
Diarrheal diseases are a leading cause of global morbidity and mortality, disproportionately affecting children in resource-limited settings. Although improvements in hygiene and access to clean water are helpful, vaccines are...
2.
Talaat K, Alaimo C, Martin P, Louis Bourgeois A, Dreyer A, Kaminski R, et al.
EBioMedicine
. 2021 Apr;
66:103310.
PMID: 33862589
Background: Shigellosis is a major cause of moderate to severe diarrhoea and dysentery in children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine conjugates the...
3.
Ravenscroft N, Braun M, Schneider J, Dreyer A, Wetter M, Haeuptle M, et al.
Glycobiology
. 2019 Jun;
29(9):669-680.
PMID: 31206156
Shigellosis remains a major cause of diarrheal disease in developing countries and causes substantial morbidity and mortality in children. Vaccination represents a promising preventive measure to fight the burden of...
4.
Huttner A, Hatz C, Dobbelsteen G, Abbanat D, Hornacek A, Frolich R, et al.
Lancet Infect Dis
. 2017 Feb;
17(5):528-537.
PMID: 28238601
Background: Escherichia coli infections are increasing worldwide in community and hospital settings. The E coli O-antigen is a promising vaccine target. We aimed to assess the safety and immunogenicity of...
5.
Favuzza P, Guffart E, Tamborrini M, Scherer B, Dreyer A, Rufer A, et al.
Elife
. 2017 Feb;
6.
PMID: 28195038
Invasion of erythrocytes by merozoites is a composite process involving the interplay of several proteins. Among them, the Cysteine-Rich Protective Antigen (PfCyRPA) is a crucial component of a ternary complex,...
6.
Favuzza P, Blaser S, Dreyer A, Riccio G, Tamborrini M, Thoma R, et al.
Malar J
. 2016 Mar;
15:161.
PMID: 26979066
Background: The pathogenesis of malaria is primarily associated with blood-stage infection and there is strong evidence that antibodies specific for parasite blood-stage antigens can control parasitaemia. This provides a strong...
7.
Bolz M, Benard A, Dreyer A, Kerber S, Vettiger A, Oehlmann W, et al.
PLoS Negl Trop Dis
. 2016 Feb;
10(2):e0004431.
PMID: 26849213
Background: Buruli ulcer, caused by infection with Mycobacterium ulcerans, is a chronic ulcerative neglected tropical disease of the skin and subcutaneous tissue that is most prevalent in West African countries....
8.
McGuire A, Dreyer A, Carbonetti S, Lippy A, Glenn J, Scheid J, et al.
Science
. 2014 Dec;
346(6215):1380-1383.
PMID: 25504724
Some HIV-infected individuals develop broadly neutralizing antibodies (bNAbs), whereas most develop antibodies that neutralize only a narrow range of viruses (nNAbs). bNAbs, but not nNAbs, protect animals from experimental infection...
9.
McGuire A, Hoot S, Dreyer A, Lippy A, Stuart A, Cohen K, et al.
J Exp Med
. 2013 Mar;
210(4):655-63.
PMID: 23530120
Broadly neutralizing antibodies (bnAbs) against HIV are believed to be a critical component of the protective responses elicited by an effective HIV vaccine. Neutralizing antibodies against the evolutionarily conserved CD4-binding...
10.
Dreyer A, Matile H, Papastogiannidis P, Kamber J, Favuzza P, Voss T, et al.
J Immunol
. 2012 May;
188(12):6225-37.
PMID: 22593616
An effective malaria vaccine could prove to be the most cost-effective and efficacious means of preventing severe disease and death from malaria. In an endeavor to identify novel vaccine targets,...